Meta Platforms (META) stock has dropped about 16% over the past 21 trading days. This recent decline signals renewed worries regarding slowing user growth and substantial investments in artificial intelligence and reality labs, but significant drops like this often raise a more difficult question: is this weakness temporary, or an indication of deeper issues in the narrative?

UnitedHealth stock (NYSE: UNH) has faced significant pressure this year, creating a potential setup for a major rally.

Viatris Inc. ( VTRS ) Jefferies London Healthcare Conference 2025 November 18, 2025 6:30 AM EST Company Participants Scott Smith - CEO & Director Theodora Mistras - Chief Financial Officer Philippe Martin - Chief R&D Officer Corinne Le Goff - Chief Commercial Officer Conference Call Participants Yuchen Ding - Jefferies LLC, Research Division Presentation Yuchen Ding Jefferies LLC, Research Division Hi. Good morning.

Lloyds Banking Group plc ( LYG ) JPMorgan UK Leaders Conference November 18, 2025 3:45 AM EST Company Participants William Leon Chalmers - Group CFO & Executive Director Conference Call Participants Sheel Shah - JPMorgan Chase & Co, Research Division Presentation Sheel Shah JPMorgan Chase & Co, Research Division Great. We can get started.

Alphabet stock has risen amid excitement over the artificial-intelligence boom but its CEO sees "elements of irrationality" in AI investment.

Home Sales Rise Year Over Year as Market Adjusts to Longer Selling Times DENVER , Nov. 18, 2025 /PRNewswire/ -- October brought encouraging signs for the housing market, with home sales up 3.2% compared to October 2024 across 51 metro areas surveyed. It was the fifth month in 2025 where sales exceeded last year's levels.

More than 20 years of financial and operational leadership in biopharma, including $170M+ in capital raised, global commercialization experience, and a proven track record scaling companies from preclinical to clinical milestones More than 20 years of financial and operational leadership in biopharma, including $170M+ in capital raised, global commercialization experience, and a proven track record scaling companies from preclinical to clinical milestones

New York, New York--(Newsfile Corp. - November 18, 2025) - If you suffered a loss on your Molina Healthcare, Inc. (NYSE: MOH) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/molina-healthcare-inc-lawsuit-submission-form?prid=177903&wire=5&utm_campaign=21 or contact Joseph E. Levi, Esq.

Fiscal Year 2025 Revenue increases 18% Year over Year to $34.9 Million Strong Enterprise AI Adoption Across Industry Sectors and Global Expansion Fueled by Leading AI-Powered Software SINGAPORE and SAN DIEGO, Nov. 18, 2025 (GLOBE NEWSWIRE) -- Helport AI Limited (NASDAQ: HPAI) (“We,” “Helport AI,” or the “Company”), an artificial intelligence (“AI”) technology company serving enterprise clients with intelligent customer communication software and services, today announced financial results for its fiscal year ended June 30, 2025. Fiscal Year 2025 Highlights: Average monthly subscribed seats were 40,935 for the fiscal year ended June 30, 2025, representing an increase of 41.49% % …

Vivid Seats customers and MileagePlus® members can earn miles for flights, upgrades, and more when purchasing tickets to live events around the world Vivid Seats customers and MileagePlus® members can earn miles for flights, upgrades, and more when purchasing tickets to live events around the world

Digital investments and disciplined inventory management strengthen supply-chain reliability for U.S. manufacturers Digital investments and disciplined inventory management strengthen supply-chain reliability for U.S. manufacturers

November 18, 2025 – TheNewswire - London, Ontario – Peloton Minerals Corporation (“Peloton” or the “Company”) (CSE Symbol: PMC; OTCQB Symbol: PMCCF)) is pleased to announce that the maiden drilling program has commenced on the Company's North Elko Lithium Project (NELP) located in northeastern Nevada. The exploration drilling targets subsurface lithium-bearing claystone layers and potentially other critical minerals. The overall target area is about 30 square kilometers (11.5 square miles) in dimension and has been identified through a series of systematic surface exploration programs conducted over the past two field seasons.

BRISBANE, Calif., Nov. 18, 2025 (GLOBE NEWSWIRE) -- Day One Biopharmaceuticals, Inc. (Nasdaq: DAWN) (“Day One” or the “Company”), a biopharmaceutical company dedicated to developing and commercializing targeted therapies for people of all ages with life-threatening diseases, today announced that management will participate in a fireside chat at the Piper Sandler 37th Annual Healthcare Conference on Tuesday, December 2, 2025 at 4:00 p.m. EST.

VANCOUVER, British Columbia, Nov. 18, 2025 (GLOBE NEWSWIRE) -- Standard Lithium Ltd. (“Standard Lithium” or the “Company”) (TSXV: SLI) (NYSE.A: SLI), a leading near-commercial lithium company, will have senior leadership participating in multiple upcoming investor conferences.

LONDON and NEW YORK, Nov. 18, 2025 (GLOBE NEWSWIRE) -- OKYO Pharma Limited (NASDAQ: OKYO), an ophthalmology-focused bio-pharmaceutical company which is developing urcosimod to treat neuropathic corneal pain (NCP), an ocular condition associated with chronic and often severe nerve-related pain but without an FDA-approved therapy, announced that Gary S. Jacob, Ph.D., Chief Executive Officer, will present at the Ophthalmology Innovation Summit (OIS) XV. The presentation is scheduled for Saturday, November 22, 2025, from 8:30-9:30 AM PT, as part of the "Anterior Innovation Showcase" session.

GARLAND, Texas , Nov. 18, 2025 /PRNewswire/ -- Massimo Group (NASDAQ: MAMO), a manufacturer and distributor of powersports and electric vehicles, today announced that the Company has received orders from retail and dealer partners for more than 4,000 units to be delivered in the next two months, representing over $20 million revenue that will be reflected in the Company's Q4 financials, pushing toward a strong year-end close. The Company is executing a series of holiday sales promotions across its product lineup—including UTVs, ATVs, and youth models—to meet demand and strengthen its retail presence nationwide.

This latest approval further broadens global access to ProSense® and supports IceCure's commercial momentum following the U.S. Food and Drug Administration's ("FDA") recent marketing authorization of ProSense® in low-risk breast cancer CAESAREA, Israel , Nov. 18, 2025 /PRNewswire/ -- IceCure Medical Ltd. (NASDAQ: ICCM) ("IceCure", "IceCure Medical" or the "Company"), developer of minimally-invasive cryoablation technology that destroys tumors by freezing as an option to surgical tumor removal, today announced that the ProSense® system and cryoprobes for the treatment of malignant or benign tissue of the breast, lung, liver, kidney, and musculoskeletal (bone), including palliative interventions, has been officially registered and …

NEW YORK and TOKYO, Nov. 18, 2025 (GLOBE NEWSWIRE) -- HeartCore Enterprises, Inc. (Nasdaq: HTCR) (“HeartCore” or the “Company”), an IPO consulting services company based in Tokyo, reported financial results for the third quarter and nine months ended September 30, 2025. Third Quarter 2025 and Recent Operational & Financial Highlights Divested software business subsidiary, HeartCore Co., Ltd (“HeartCore Japan”) Authorized one-time distribution payment to stockholders Announced Go IPO client, rYojbaba Co., Ltd.

The top-line results showed that bioavailability of Aramchol meglumine 400mg and 200mg granules is considerably greater, higher by 5-fold and 3-fold respectively, that of the Aramchol free acid 300mg tablets The new unexpected PK profile allows for a once daily therapeutic regimen thus potentially improving long term adherence and expected to significantly reduce the drug cost of goods RAMAT-GAN, Israel , Nov. 18, 2025 /PRNewswire/ -- Galmed Pharmaceuticals Ltd. (Nasdaq: GLMD) ("Galmed" or the "Company"), a clinical-stage biopharmaceutical company focused on liver, cardiometabolic, and gastrointestinal oncology indications, today announced meaningful top-line results from Galmed's AM-001 Study, a Phase 1 Bioavailability …

BOCA RATON, FL, Nov. 18, 2025 (GLOBE NEWSWIRE) -- DeFi Development Corp. (Nasdaq: DFDV) (the “Company”), the first public company with a treasury strategy built to accumulate and compound Solana (“SOL”), today announced that it has signed a Letter of Intent (LOI) with Loopscale, a modular, orderbook-based lending protocol on Solana. The LOI outlines the Company's plan to deploy a portion of its SOL and stablecoin reserves into Loopscale's lending and vault ecosystem to generate yield, participate in the platform's Points program, and support long-term SOL Per Share (SPS) growth.